989P Disease etiology and efficacy outcomes with atezolizumab plus bevacizumab (atezo-bev) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Multinational retrospective analysis

S. Kim,S.Y. Lee, Y.G. Park,H-D. Kim, J.J.X. Lee, M.H. Ryu,B-Y. Ryoo,D.W.M. Tai, C. Yoo

Annals of Oncology（2023）

引用 0|浏览5

暂无评分

关键词

hepatocellular carcinoma,unresectable hepatocellular carcinoma,atezolizumab,bevacizumab,atezo-bev

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要